Your browser is no longer supported. Please, upgrade your browser.
Settings
PBYI Puma Biotechnology, Inc. daily Stock Chart
PBYI [NASD]
Puma Biotechnology, Inc.
Index- P/E- EPS (ttm)-8.08 Insider Own11.60% Shs Outstand37.54M Perf Week5.30%
Market Cap3.54B Forward P/E- EPS next Y-3.75 Insider Trans-31.65% Shs Float31.97M Perf Month17.51%
Income-277.90M PEG- EPS next Q-2.03 Inst Own95.30% Short Float19.48% Perf Quarter153.84%
Sales- P/S- EPS this Y-11.30% Inst Trans1.79% Short Ratio3.71 Perf Half Y192.40%
Book/sh4.53 P/B20.82 EPS next Y55.60% ROA-143.60% Target Price97.88 Perf Year173.17%
Cash/sh5.17 P/C18.25 EPS next 5Y- ROE-186.70% 52W Range28.35 - 97.14 Perf YTD207.17%
Dividend- P/FCF- EPS past 5Y-44.40% ROI- 52W High-2.93% Beta0.57
Dividend %- Quick Ratio4.70 Sales past 5Y- Gross Margin- 52W Low232.63% ATR4.34
Employees160 Current Ratio4.70 Sales Q/Q- Oper. Margin- RSI (14)67.21 Volatility5.39% 4.65%
OptionableYes Debt/Eq0.00 EPS Q/Q9.70% Profit Margin- Rel Volume0.51 Prev Close94.75
ShortableYes LT Debt/Eq0.00 EarningsAug 09 AMC Payout- Avg Volume1.68M Price94.30
Recom1.60 SMA206.49% SMA5026.09% SMA20096.30% Volume855,917 Change-0.47%
Jul-10-17Resumed Leerink Partners Outperform $115
Jun-06-17Reiterated RBC Capital Mkts Sector Perform $60 → $88
May-25-17Reiterated RBC Capital Mkts Sector Perform $40 → $60
Mar-02-17Reiterated RBC Capital Mkts Sector Perform $48 → $17
Sep-22-16Reiterated Credit Suisse Outperform $54 → $111
Sep-21-16Upgrade Stifel Hold → Buy $61 → $88
Mar-29-16Downgrade RBC Capital Mkts Outperform → Sector Perform $103 → $36
Jan-21-16Initiated Credit Suisse Outperform
Dec-14-15Upgrade Citigroup Neutral → Buy
Sep-03-15Initiated Citigroup Neutral
Aug-27-15Initiated JP Morgan Overweight $122
Jan-23-15Initiated RBC Capital Mkts Outperform $282
Aug-19-14Resumed Stifel Hold
Jul-23-14Reiterated UBS Buy $125 → $325
Dec-19-13Reiterated UBS Buy $61 → $125
Dec-19-13Downgrade Stifel Buy → Hold
Jul-22-13Reiterated Stifel Buy $42 → $64
Jun-03-13Reiterated UBS Buy $35 → $49
Mar-25-13Reiterated Stifel Buy $32 → $42
Mar-20-13Reiterated UBS Buy $27 → $35
Jul-21-17 02:42PM  3 Been-There-Done-That Biotech CEOs Who Are Doing it Again Motley Fool
Jul-18-17 09:00PM  Does Puma Biotechnology's Approval Make It Worth More? Motley Fool +8.54%
06:10PM  Puma's (PBYI) Breast Cancer Drug Neratinib Gets FDA Approval Zacks
04:21PM  Could This Biotech Stir Takeover Interest After Cancer Drug Approval? Investor's Business Daily
01:14PM  Puma Biotechnology Inc (PBYI) Drug Nerlynx Set To Hit The Market; J.P. Morgan Chimes In SmarterAnalyst
11:31AM  Puma Biotech Wins Big on FDA Approval of Breast Cancer Treatment 24/7 Wall St.
08:00AM  Today's Research Reports on Trending Tickers: Puma Biotechnology Inc. and Novavax Inc. Accesswire
Jul-17-17 07:17PM  Puma jumps after FDA approval of breast-cancer treatment MarketWatch
05:36PM  U.S. Food and Drug Administration Approves Pumas NERLYNX (neratinib) for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer Business Wire
Jul-10-17 10:57AM  Puma Biotech Is up 181% This Year; Here's Why It Can Still Go Higher Barrons.com
Jul-07-17 09:30AM  Puma (PBYI) Ends Patient Enrollment in Phase III Cancer Trial Zacks
Jul-06-17 04:15PM  Puma Biotechnology Completes Targeted Enrollment in Neratinib Phase III Metastatic Breast Cancer Trial Business Wire
Jul-03-17 08:43AM  Are Options Traders Betting on a Big Move in Puma Biotechnology (PBYI) Stock? Zacks
Jun-29-17 04:30PM  PUMA BIOTECHNOLOGY LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing in Puma Biotechnology, Inc. to Contact the Firm Business Wire
Jun-28-17 04:22PM  5 Biotech Stocks With Major Catalysts in July Motley Fool
Jun-25-17 02:01PM  5 Best Biotech Stocks of 2017 So Far Motley Fool
Jun-20-17 09:43AM  Big Money Flowing Into Biotech Stocks - Again Forbes
Jun-15-17 05:24PM  Puma (PBYI) Stock Surges as Neratinib Nears FDA Approval Zacks
Jun-13-17 11:57AM  The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Puma Biotechnology, Inc. Shareholders and a Lead Plaintiff Deadline of July 7, 2017 Business Wire
Jun-12-17 04:10PM  PUMA BIOTECHNOLOGY LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing in Puma Biotechnology, Inc. to Contact the Firm Accesswire
11:56AM  The Klein Law Firm Announces a Class Action Filed on Behalf of Puma Biotechnology, Inc. Shareholders and a Lead Plaintiff Deadline of July 7, 2017 Business Wire
Jun-09-17 07:35PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI Accesswire
Jun-08-17 11:47AM  PBYI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Puma Biotechnology, Inc. and a Lead Plaintiff Deadline of July 7, 2017 Business Wire
Jun-07-17 10:39AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Puma Biotechnology, Inc. (PBYI) and Lead Plaintiff Deadline: July 7, 2017 Accesswire
Jun-06-17 04:34PM  3 Takeaways From Monday's ASCO Meetings: Puma Biotech, Incyte, Celgene Benzinga
04:04PM  Tesla Seen Rising 26% In Model 3 'Bull Case'; Puma, Microchip, Ulta Price Targets Hiked Investor's Business Daily
08:15AM  Corporate News Blog - Puma Biotech Announced Positive Results from PB272 Phase-II Data at the ASCO, 2017 Accesswire
Jun-05-17 02:14PM  INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Puma Biotechnology, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 7, 2017 Business Wire
09:20AM  Lawsuit for Investors in (NASDAQ: PBYI) Shares Against Puma Biotechnology Inc. Announced by Shareholders Foundation Accesswire
07:30AM  'APHINITY' Study Spells Major Trouble for Roche, Another Win for Puma Bio TheStreet.com
Jun-03-17 03:50PM  Puma Biotechnology Announces Positive PB272 Phase II Data from TBCRC 022 Trial in Patients with HER2-Positive Metastatic Breast Cancer with Brain Metastases at the 2017 ASCO Annual Meeting Business Wire
Jun-02-17 08:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI Accesswire
12:52PM  PBYI INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Puma Biotechnology, Inc. and a Lead Plaintiff Deadline of July 7, 2017 Business Wire
09:30AM  Universal Display, Hewlett Packard, Regeneron Pharmaceuticals, Sangamo Therapeutics and Puma Biotechnology highlighted as Zacks Bull and Bear of the Day Zacks
Jun-01-17 04:29PM  PUMA BIOTECHNOLOGY LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Puma Biotechnology, Inc. To Contact The Firm GlobeNewswire +6.73%
May-31-17 04:17PM  Puma Biotechnology to Present at the Jefferies 2017 Healthcare Conference Business Wire
May-30-17 10:59AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Puma Biotechnology, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 7, 2017 Business Wire
May-26-17 07:00PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI Accesswire
09:48AM  Puma Soaring After Neratinib FDA Panel Win, Time to Buy? Zacks
07:11AM  Will Puma Biotechnology (PBYI) Continue to Surge Higher? Zacks
May-25-17 11:18AM  Bullish Puma Investor Talks Neratinb FDA Panel Win, Next Steps and Takeout Potential TheStreet.com
10:36AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Puma Biotechnology, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 7, 2017 - PBYI Accesswire
09:37AM  Biotech Movers: Positive Phase Three Results For Roclatan Send Aerie Shares Soaring TheStreet.com
08:43AM  Biotech And Pharma Industry And Stock News Investor's Business Daily
08:15AM  Puma Biotechnology (PBYI) Jumps: Stock Adds 29.7% in Session Zacks
May-24-17 04:38PM  This Biotech Stock Has Soared 84% This Week On Breast-Cancer Drug News Investor's Business Daily +29.67%
04:17PM  Why Abercrombie & Fitch, Triumph Group, and Puma Biotechnology Jumped Today Motley Fool
03:49PM  Why Puma Biotechnology Inc Jumped Higher Today Motley Fool
02:54PM  Puma Biotech shares surge 20% after FDA advisory committee votes in favor of approving breast cancer drug MarketWatch
01:36PM  Puma Biotech Gets Favorable FDA Vote On Neratinib Benzinga
01:29PM  Puma Biotechnology Receives FDA Advisory Committee Support for Neratinib Business Wire
12:32PM  FDA Panel Votes 12 To 4 to Approve Puma's Breast Cancer Drug Forbes
10:38AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Puma Biotechnology, Inc. (PBYI) and Lead Plaintiff Deadline: July 7, 2017 Accesswire
08:12AM  Puma Biotechnology FDA Live Blog Forbes
May-23-17 08:59AM  The Current State Of The Breast Cancer Treatment Space Benzinga +9.89%
May-22-17 04:23PM  Why Puma Biotechnology, Applied Optoelectronics, and Ferroglobe Jumped Today Motley Fool +39.15%
04:09PM  Puma Biotech Surges To 6-Month High On Likely Cancer Drug Approval Investor's Business Daily
02:14PM  Puma Biotech Shares Are Roaring On An FDA Review. Here's What Could Still Go Wrong Forbes
01:05PM  Why Puma Biotechnology Inc Jumped Higher Today Motley Fool
11:17AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Puma Biotechnology, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 7, 2017 - PBYI Accesswire
10:41AM  Puma Bio Bulls Win Monday's FDA Neratinib Review, Ahead of Wednesday's Advisory Panel Vote TheStreet.com
10:08AM  Puma Biotechnology Announces Posting of FDA Oncologic Drugs Advisory Committee Briefing Documents for Neratinib Meeting Business Wire
09:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline PBYI GlobeNewswire
08:32AM  Are Options Traders Betting on a Big Move in Puma (PBYI) Stock? Zacks
May-19-17 04:36PM  Harwood Feffer LLP Announces Investigation of Puma Biotechnology, Inc. PR Newswire
May-18-17 07:49PM  PUMA BIOTECHNOLOGY LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Puma Biotechnology, Inc. To Contact The Firm PR Newswire +6.21%
12:01PM  PBYI INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Puma Biotechnology, Inc. and a Lead Plaintiff Deadline of July 7, 2017 Accesswire
08:00AM  Today's Research Reports on Biotech Stocks to Watch: Pulmatrix and Puma Biotechnology Accesswire
May-17-17 05:06PM  Puma Biotechnology Announces Publication of Neratinib Abstract for the 2017 ASCO Annual Meeting Business Wire +13.46%
04:37PM  Puma Leaps On Report Its Breast Cancer Drug Could Rival Roche Investor's Business Daily
10:10AM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Puma Biotechnology, Inc. (PBYI) and Lead Plaintiff Deadline: July 7, 2017 GlobeNewswire
09:48AM  Reasons to Add Puma Biotechnology (PBYI) to Portfolio Now Zacks
May-16-17 08:57AM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Puma Biotechnology, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 7, 2017 - PBYI Accesswire
May-15-17 02:34PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Puma Biotechnology, Inc. GlobeNewswire
02:18PM  The Klein Law Firm Announces a Class Action Filed on Behalf of Puma Biotechnology, Inc. Shareholders and a Lead Plaintiff Deadline of July 7, 2017 (PBYI) GlobeNewswire
May-12-17 06:45PM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Puma Biotechnology, Inc. of Class Action Lawsuit and Upcoming Deadline - PBYI PR Newswire
08:45AM  PBYI SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Puma Biotechnology, Inc. and a Lead Plaintiff Deadline of July 7, 2017 GlobeNewswire
May-11-17 01:53PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Puma Biotechnology, Inc. (PBYI) and Lead Plaintiff Deadline: July 7, 2017 PR Newswire
11:32AM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Puma Biotechnology, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of July 7, 2017 PBYI GlobeNewswire
08:44AM  Puma (PBYI) Q1 Loss Narrows, Focus Remains on Neratinib Zacks
May-10-17 08:30PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Puma Biotechnology, Inc. (Nasdaq: PBYI) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire
07:36PM  Robbins Arroyo LLP: Puma Biotechnology, Inc. (PBYI) Misled Shareholders According to a Recently Filed Class Action Business Wire
05:54PM  Puma Biotech reports 1Q loss Associated Press
04:20PM  Puma Biotechnology Reports First Quarter 2017 Financial Results Business Wire
May-09-17 04:20PM  Puma Biotechnology to Present at Bank of America Merrill Lynch 2017 Health Care Conference Business Wire
May-08-17 11:23PM  PUMA BIOTECHNOLOGY LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Puma Biotechnology, Inc. To Contact The Firm Business Wire -5.54%
04:05PM  PUMA BIOTECHNOLOGY INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Puma Biotechnology, Inc. To Contact The Firm Business Wire
03:16PM  Pomerantz Law Firm Announces the Filing of a Class Action against Puma Biotechnology, Inc. and Certain Officers PBYI GlobeNewswire
May-05-17 05:00PM  Why Puma Biotechnology, Trex, and National CineMedia Slumped Today Motley Fool -16.01%
01:10PM  Why Puma Biotechnology Shares Are Crashing 18.2% Today Motley Fool
12:19PM  SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Puma Biotechnology, Inc. (PBYI) PR Newswire
12:08PM  PUMA BIOTECHNOLOGY INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Puma Biotechnology, Inc. To Contact The Firm PR Newswire
10:19AM  SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Puma Biotechnology, Inc. - PBYI PR Newswire
06:53AM  A Top Puma Bio Exec Resigns Ahead of FDA Panel, Analysts Defend With Conflicting Stories TheStreet.com
May-03-17 10:44AM  Puma Biotechnology (PBYI) Q1 Earnings: Stock to Disappoint? Zacks -5.00%
Apr-18-17 01:31PM  Shortened FDA Advisory Panel Is Bad Omen for Puma Bio's Controversial Breast Cancer Drug TheStreet.com -6.94%
Apr-17-17 08:03AM  Puma Biotechnology Announces FDA Advisory Committee to Review Neratinib for the Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer Business Wire +11.08%
Apr-04-17 01:05PM  Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of PB272 in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2017 AACR Annual Meeting Business Wire
01:05PM  Puma Biotechnology Presents Interim Results of Phase II CONTROL Trial of PB272 in Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer at the 2017 AACR Annual Meeting
Apr-02-17 03:03PM  Puma Biotechnology Presents Interim Results of Phase Ib/II FB-10 Trial of PB272 in Combination with Trastuzumab Emtansine (T-DM1) in HER2-Positive Metastatic Breast Cancer at the 2017 AACR Annual Meeting Business Wire
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to improve cancer care. Its drug candidates include PB272 (neratinib (oral)) for the treatment of early stage breast cancer, metastatic breast cancer, non-small cell lung cancer, HER2 mutation-positive solid tumors, and HER2-mutated non-amplified breast cancer; and PB272 (neratinib (intravenous)). The company also develops PB357, an orally administered agent that is an irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2, and HER4. It has a license agreement with Pfizer, Inc. for the development, manufacture, and commercialization of PB272 neratinib (oral), PB272 neratinib (intravenous), PB357, and certain related compounds. Puma Biotechnology, Inc. was founded in 2010 and is headquartered in Los Angeles, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BRYCE RICHARD PAULSR VP, CLINICAL RESEARCH & DEVJul 03Option Exercise11.305,00056,50034,237Jul 14 06:01 PM
BRYCE RICHARD PAULSR VP, CLINICAL RESEARCH & DEVJul 03Sale87.105,000435,50029,237Jul 14 06:01 PM
ADAGE CAPITAL PARTNERS GP, L.L10% OwnerJun 12Sale79.3188,9447,053,8703,696,580Jun 12 06:45 PM
ADAGE CAPITAL PARTNERS GP, L.L10% OwnerJun 09Sale80.7758,3164,710,4303,785,524Jun 12 06:45 PM
ADAGE CAPITAL PARTNERS GP, L.L10% OwnerJun 08Sale80.95100,0008,094,6103,843,840Jun 12 06:45 PM
ADAGE CAPITAL PARTNERS GP, L.L10% OwnerJun 05Sale91.29307,12828,037,0323,943,840Jun 05 05:58 PM
ADAGE CAPITAL PARTNERS GP, L.L10% OwnerJun 02Sale83.0630,4752,531,2874,250,968Jun 05 05:58 PM
ADAGE CAPITAL PARTNERS GP, L.L10% OwnerJun 01Sale82.45169,52513,976,6574,281,443Jun 05 05:58 PM
ADAGE CAPITAL PARTNERS GP, L.L10% OwnerMay 26Sale77.07300,00023,121,2634,450,968May 26 04:40 PM
ADAGE CAPITAL PARTNERS GP, L.L10% OwnerMay 25Sale77.87400,00031,146,5604,750,968May 26 04:40 PM
ADAGE CAPITAL PARTNERS GP, L.L10% OwnerMay 24Sale72.57535,70038,876,4455,150,968May 26 04:40 PM
CHARNAS ROBERTFeb 01Sale31.833,00895,75526,453Feb 02 05:43 PM
Lo StevenChief Commercial OfficerJan 20Sale33.242,29076,10829,210Jan 24 05:56 PM
EYLER CHARLES RSEE REMARKSJan 20Sale33.2482027,2539,680Jan 24 05:53 PM
CHARNAS ROBERTJan 20Sale33.242,29376,20829,407Jan 24 05:52 PM
BRYCE RICHARD PAULSR VP, CLINICAL RESEARCH & DEVJan 20Sale33.242,29376,20829,237Jan 24 05:51 PM
AUERBACH ALAN HPRESIDENT AND CEOJan 20Sale33.2410,202339,0644,179,798Jan 24 05:49 PM
SOXL Direxion Daily Semicondct Bull 3X ETF daily Stock Chart
SOXL [NYSE]
Direxion Daily Semicondct Bull 3X ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week0.56%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month4.36%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter34.15%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.24 Perf Half Y61.33%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year207.88%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range31.22 - 113.08 Perf YTD73.22%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-12.53% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low216.82% ATR4.58
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)58.88 Volatility3.11% 4.96%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.80 Prev Close101.51
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume517.57K Price98.91
Recom- SMA209.01% SMA507.03% SMA20042.49% Volume416,580 Change-2.56%
Jul-21-17 08:31PM  5 Top Semiconductor ETFs Motley Fool
Jul-12-17 04:25PM  Top 5 Semiconductor ETFs for 2017 Investopedia
Jun-05-17 11:30AM  5 Ways to Play Unstoppable Tech Rally with ETFs Zacks
Jun-01-17 10:51AM  5 Best Performing Leveraged ETFs of May Zacks
May-18-17 01:08PM  Will Semiconductors Have Fun in the Sun This Summer? Market Realist +5.73%
10:54AM  Controversial ETFs that would have delivered four times the market hit a snag CNBC
Apr-17-17 01:16PM  These Are The Hot Leveraged Sector ETFs Heading Into This Week Benzinga
Apr-04-17 10:38AM  Which Sectors Are Likely to Outperform in the Short Term? Market Realist
10:38AM  Which Sectors Are Likely to Outperform in the Short Term?
09:02AM  How Trumps Proposed Policies Have Caused Sector Divergence Market Realist
09:02AM  How Trumps Proposed Policies Have Caused Sector Divergence
Mar-31-17 12:11PM  5 Best Performing Inverse/Leveraged ETFs of March Zacks
12:11PM  5 Best Performing Inverse/Leveraged ETFs of March
Jan-03-17 10:53AM  Top 5 Semiconductor ETFs of 2016 at Investopedia
Dec-28-16 02:07PM  6 Best Performing Leveraged ETFs of 2016 Zacks -5.81%
02:07PM  6 Best Performing Leveraged ETFs of 2016
Nov-22-16 09:27AM  Bull Market Here to Stay: 10 ETF Ways to Play Zacks
09:27AM  Bull Market Here to Stay: 10 ETF Ways to Play
Oct-04-16 12:15AM  Best and Worst Performing ETFs of Q3 2016 (SOXL, LABU) Investopedia
12:15AM  Best and Worst Performing ETFs of Q3 2016 (SOXL, LABU) at Investopedia
Oct-03-16 10:58AM  5 Best Performing Leveraged ETFs of September Zacks
10:58AM  5 Best Performing Leveraged ETFs of September
Aug-08-16 05:09PM  How Volatility Affects 2 Popular Leveraged ETFs Benzinga
05:09PM  How Volatility Affects 2 Popular Leveraged ETFs
Jul-22-16 08:16AM  A Rocking Russia ETF
Jul-19-16 01:35PM  Loving Leveraged Bond ETFs
Jul-18-16 01:56PM  SoftBank, ARM Deal Helps Semiconductor ETF Push Higher
Jun-30-16 01:26PM  A Brexit Boon For These Leveraged ETFs +5.45%
Jun-16-16 01:45PM  Listen To What Leveraged S&P 500 ETFs Are Saying
Jun-10-16 09:21AM  A Conservative Way To Short The S&P 500 -5.02%
May-31-16 01:59PM  Suddenly Super Semiconductor ETFs; But Is It A Home Run?
May-27-16 01:11PM  This Biotech ETF Could Be Ready To Party
May-20-16 01:52PM  Applied Materials Earnings Beat Helps Semiconductor ETFs Power Up +9.31%
01:30PM  ETF TMI: Latest ETF Launches, Transitions & Jumps
10:54AM  Monitoring Oil Services ETFs Schlumberger, Halliburton
10:51AM  If Rates Rise, Look to These Junk Bond ETFs
10:46AM  Amazon, Wal-Mart Will Lift This Retail ETF
10:40AM  Corn ETF Looks to Breakout
10:34AM  Steady Swiss ETFs Ready to Rally
08:25AM  Bank on Financial ETFs in Rising Rate Environment
08:15AM  Getting Tactical for the Long Term
May-19-16 04:26PM  41 Target Maturity Bond ETFs for Rising Rates
May-18-16 08:20AM  Dollar ETFs Look for Green
May-08-16 12:25PM  USD vs. SOXL: Comparing Leveraged Semiconductor ETFs at Investopedia
Apr-22-16 05:51AM  Gold Miner ETFs Are Having the Rally of a Lifetime and Burned Investors Are Missing It at Bloomberg
Apr-12-16 08:15AM  Leveraged Energy ETFs For Earnings Season
Apr-08-16 08:41AM  New Inverse ETFs For Bearish Sector Traders
Mar-23-16 01:45AM  How To Trade Leveraged ETFs
Mar-17-16 07:27AM  Rousseff Is A Problem For Brazil Leveraged ETF
Mar-08-16 08:11AM  Brazil ETF's Rise Stokes Volume Spike In Leveraged Counterpart -6.81%
Mar-02-16 01:58PM  These Bond ETFs Are On Fire
01:04PM  The strange ETF thats doubled this year at CNBC
Feb-26-16 03:03PM  Some Say The Gold Miners Trade Is Back
Feb-12-16 08:11AM  This Little Nugget Of An ETF Is Delivering Astounding Returns +6.61%
Feb-04-16 01:19PM  Leveraged Miners ETF Struts Its Stuff
Jan-29-16 08:34AM  Gold Miner ETFs Rake In Assets Despite Dismal Performance +13.50%
Jan-26-16 06:47AM  Traders Are Missing Out On The Right China ETFs
Jan-20-16 02:03PM  6 Inverse Leveraged ETFs Up Over 50% YTD
Jan-12-16 09:30AM  The Zacks Analyst Blog Highlights: Direxion Daily S&P Biotech Bear 3x Shares, VelocityShares 3x Inverse Crude ETN, ProShares UltraProShort Nasdaq Biotechnology, Direxion Daily FTSE China Bear 3x Shares and Direxion Daily Semiconductor Bear
Jan-11-16 10:18AM  6 Inverse Leveraged ETFs Soaring to Start 2016
06:14AM  Traders Aren't Displaying Much Confidence In Leveraged Gold Miner ETFs
Dec-22-15 07:56AM  Russia ETFs On The Rocks...Except For One
Dec-11-15 09:36AM  Using Leveraged Energy ETFs As Rising Rates Plays -5.88%
Dec-03-15 02:17PM  A New Bearish Biotech ETF And A Lazarus Act For A Couple Leveraged Funds
Nov-23-15 01:52PM  The One Retail ETF That Isn't Disappointing
Nov-21-15 02:02PM  Russia Rally Reveals Love For Leverage
Nov-18-15 03:50PM  Gold Miners ETFs Are Getting Smoked
Nov-10-15 06:28AM  Digging Deep With Leveraged Gold Miner ETFs As Higher Rates Loom -5.44%
Nov-09-15 02:58PM  Rate Hike Odds Shine A Light On Leveraged Gold Miners ETFs
Oct-15-15 07:46AM  Here's How Traders Have Once Again Botched The Gold Miners Trade
Oct-13-15 09:30AM  The Zacks Analyst Blog Highlights: ERX,DIG,GASL,GUSH and UOP
07:15AM  How To Use Leveraged ETFs To Beat The Fed
Oct-09-15 12:06AM  Bill Gross Believes Every Asset Price Is Artificially Elevated
Oct-05-15 02:26PM  Bullish Leveraged Gold Miners ETFs Are On Fire +5.57%
Sep-28-15 03:57PM  Wild Ride For Leveraged Biotech ETFs Continues -8.34%
Sep-15-15 03:43PM  Not DUST In The Wind: Perhaps The Best Gold Miners ETF
Aug-26-15 01:02PM  Traders Are Getting It Wrong With Leveraged Emerging Markets ETFs +14.88%
Aug-21-15 02:43PM  The Right ETF For Russia Right Now -7.08%
Aug-14-15 03:29PM  Well Look At That: Gold Miners ETFs Try To Bounce Back
Aug-11-15 03:31PM  Dancing With The Devil: Looking For Bottoms With Leveraged Bull Energy ETFs -6.80%
Aug-10-15 07:03AM  Leveraged Gold Miners ETFs To Host Reverse Split Party +7.50%
Aug-07-15 05:29PM  Direxion Announces ETF Splits: 3X Bullish Gold Miners to See 1-for-10 Reverse at Barrons.com
Aug-05-15 03:42PM  For The Bold: Bearish Energy ETF Ideas
Aug-04-15 09:30AM  The Zacks Analyst Blog Highlights: Direxion Daily Gold Miners Index Bear 3x Shares, VelocityShares 3x Inverse Crude ETN, Direxion Daily Junior Gold Miners Index Bear 3x Shares and ProShares UltraShort Gold Miners ETF - Press Releases
Jul-28-15 10:00AM  Enter the Bear: How to Win With ETFs as Chinese Stocks Tumble at TheStreet +6.23%
Jul-27-15 10:03AM  A Look Ahead: Biotech And Energy ETFs To Watch This Week
May-20-15 01:17PM  Processing a Leveraged ETF Trade Idea
Mar-30-15 02:00PM  Intel/Altera Rumor Stokes Inflows to Leveraged Chip ETF
Mar-27-15 02:16PM  Semiconductor ETFs Could See Further Pain
Dec-17-14 03:55PM  10 Best Leveraged ETFs of 2014
Sep-15-14 12:18PM  Semiconductors Selloff After Failed Breakout
Jul-15-14 02:22PM  Big Earnings Week for This Semiconductor ETF
May-27-14 03:33PM  Leveraged ETF Roundup: Russia, India & Semiconductor Lead
May-15-14 03:47PM  How AMD's Market Share Can Rise To 30% After The MacPro Deal at Seeking Alpha
May-02-14 06:12PM  What To Expect From Qualcomm at Seeking Alpha
Apr-28-14 11:20AM  NXP's Buyback, Q1 Results And Sell Side Commentary at Seeking Alpha
Apr-25-14 03:12PM  Qualcomm's Revenue Growth Slows Amid Smartphone Saturation, Slow LTE Sales In China at Seeking Alpha
Apr-24-14 06:40PM  Remaining A Little Nervously Long Qualcomm at Seeking Alpha
Apr-22-14 04:19PM  Qualcomm Earnings Preview: Chipset And Device ASPs In Focus Amid High-End Saturation at Seeking Alpha
Apr-21-14 08:35PM  AMD: Now With Lower Risk And Greater Upside at Seeking Alpha
The investment seeks daily investment results, before fees and expenses, of 300% of the daily performance of the PHLX Semiconductor Sector Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments that provide daily leveraged exposure to the index and/or exchange-traded funds ("ETFs") that track the index. The index measures the performance of domestic companies engaged in the design, distribution, manufacture and sale of semiconductors. The fund is non-diversified.
ABCO The Advisory Board Company daily Stock Chart
ABCO [NASD]
The Advisory Board Company
Index- P/E23.08 EPS (ttm)2.48 Insider Own1.50% Shs Outstand40.34M Perf Week0.00%
Market Cap2.31B Forward P/E26.80 EPS next Y2.13 Insider Trans-14.10% Shs Float39.97M Perf Month11.50%
Income100.60M PEG1.77 EPS next Q0.44 Inst Own- Short Float4.81% Perf Quarter20.42%
Sales797.20M P/S2.89 EPS this Y178.60% Inst Trans0.39% Short Ratio4.56 Perf Half Y33.96%
Book/sh13.62 P/B4.20 EPS next Y8.49% ROA5.10% Target Price50.71 Perf Year50.13%
Cash/sh3.72 P/C15.37 EPS next 5Y13.04% ROE20.50% 52W Range24.85 - 59.50 Perf YTD72.03%
Dividend- P/FCF34.34 EPS past 5Y27.60% ROI5.90% 52W High-3.87% Beta1.35
Dividend %- Quick Ratio1.00 Sales past 5Y16.80% Gross Margin50.40% 52W Low130.18% ATR1.22
Employees3800 Current Ratio1.00 Sales Q/Q-3.10% Oper. Margin7.20% RSI (14)72.37 Volatility1.47% 2.61%
OptionableYes Debt/Eq1.10 EPS Q/Q94.00% Profit Margin12.60% Rel Volume0.93 Prev Close56.90
ShortableYes LT Debt/Eq0.99 EarningsJul 26 AMC Payout0.00% Avg Volume421.69K Price57.20
Recom2.30 SMA205.53% SMA508.85% SMA20028.45% Volume393,875 Change0.53%
Mar-27-17Upgrade Robert W. Baird Neutral → Outperform $50 → $53
Mar-10-17Downgrade SunTrust Buy → Hold
Feb-17-17Downgrade JP Morgan Overweight → Neutral
Jan-31-17Reiterated Stifel Hold $38 → $47
Jan-13-17Downgrade Piper Jaffray Overweight → Neutral
Nov-07-16Downgrade BofA/Merrill Buy → Underperform
Nov-02-16Reiterated Stifel Hold $45 → $43
Sep-30-16Reiterated Barclays Overweight $44 → $50
Jul-28-16Upgrade Craig Hallum Hold → Buy
Jul-28-16Reiterated FBR Capital Mkt Perform $35 → $37
Jul-19-16Downgrade Raymond James Outperform → Mkt Perform
Jun-20-16Initiated Credit Suisse Outperform
May-06-16Reiterated FBR Capital Mkt Perform $40 → $35
Apr-18-16Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Feb-25-16Upgrade Deutsche Bank Hold → Buy $53 → $43
Feb-24-16Downgrade Stifel Buy → Hold
Feb-24-16Downgrade Robert W. Baird Outperform → Neutral $60 → $40
Feb-24-16Downgrade FBR Capital Outperform → Mkt Perform $55 → $40
Feb-24-16Downgrade Craig Hallum Buy → Hold
Feb-24-16Downgrade Cantor Fitzgerald Buy → Hold
Jul-14-17 07:38AM  What the Advisory Boards Health Business Expects from Technology Sales Market Realist
Jul-13-17 02:05PM  Decoding the Advisory Boards Net Profit Margins in 2017 Market Realist
12:35PM  Behind the Advisory Boards Revenue Growth in 2017 Market Realist
10:57AM  The Future of the Advisory Board: Latest News and Analyst Recommendations Market Realist
Jul-10-17 05:24PM  Analysts: Advisory Board acquisition by UnitedHealthcare, Vista would make sense American City Business Journals
10:13AM  Company News for July 10, 2017 Zacks
10:10AM  Bernstein On Advisory Board Health Care Services Unit Purchase By UnitedHealth Benzinga
08:33AM  Advisory Board (ABCO) in Focus: Stock Moves 5.4% Higher Zacks
Jul-07-17 03:48PM  The Advisory Board Co. Value Analysis (NASDAQ:ABCO) : July 7, 2017 Capital Cube +5.35%
Jul-06-17 03:39PM  UnitedHealth, Vista Said Near Deal to Split Advisory Board Bloomberg
08:18AM  The Advisory Board Co. breached its 50 day moving average in a Bullish Manner : ABCO-US : July 6, 2017 Capital Cube
Jul-05-17 08:25AM  EAB Announces the Student Success Management System PR Newswire
Jul-04-17 02:23PM  ETFs with exposure to The Advisory Board Co. : July 4, 2017 Capital Cube
Jun-27-17 11:58AM  Average Hospital Revenue Cycle Leaves $22 Million on the Table PR Newswire
Jun-19-17 02:49PM  ETFs with exposure to The Advisory Board Co. : June 19, 2017 Capital Cube
09:00AM  Virtual Visits with Medical Specialists Draw Strong Consumer Demand, Survey Shows PR Newswire
Jun-08-17 01:21PM  ETFs with exposure to The Advisory Board Co. : June 8, 2017 Capital Cube
Jun-06-17 09:13AM  The Advisory Board Co. :ABCO-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017 Capital Cube
May-18-17 09:01AM  Singer's Elliott Management Eyes 'Strategic Opportunities' at Athenahealth TheStreet.com
May-12-17 05:20AM  Advisory Board alum raises $5 million for his kidney care startup American City Business Journals
May-10-17 09:00AM  Advisory Board's Dennis Weaver Shares Real-World Experience in Value-Based Care Success PR Newswire
May-09-17 08:16AM  Edited Transcript of ABCO earnings conference call or presentation 4-May-17 9:30pm GMT Thomson Reuters StreetEvents
May-05-17 03:15PM  Advisory Board reports massive jump in income despite tumultuous first quarter American City Business Journals
May-04-17 04:52PM  Advisory Board beats Street 1Q forecasts Associated Press
04:05PM  The Advisory Board Company Reports First Quarter 2017 Results PR Newswire
02:55PM  Investor Network: Advisory Board Company to Host Earnings Call Accesswire
09:30AM  Virginia's Community Colleges Select EAB Navigate to Support On-Time Completion PR Newswire
May-02-17 11:29AM  Social Media Shows Promise to Recruit Minorities to College PR Newswire
Apr-20-17 09:00AM  The Advisory Board Company to Report First Quarter Financial Results After Market Close on May 4, 2017 PR Newswire
Apr-06-17 04:42PM  Hospital Executives See Future Growth in Outpatient, Higher-Value Care, Survey Finds PR Newswire
Mar-27-17 05:15PM  Chances Of Advisory Board Getting Taken Out Just Got Considerably Higher Benzinga
10:24AM  Report: Evolent Health weighs merger with Advisory Board at bizjournals.com
10:24AM  Report: Evolent Health weighs merger with Advisory Board American City Business Journals
06:54AM  Advisory Board upgraded by Robert W. Baird
Mar-23-17 10:19AM  Allergan's Restasis Now Available in Multidose Bottle in U.S. Zacks
09:36AM  Ultragenyx's Seizure Candidate UX007 Fails in Phase II Study Zacks
08:13AM  The Advisory Board Co. breached its 50 day moving average in a Bearish Manner : ABCO-US : March 23, 2017 Capital Cube
Mar-22-17 01:04PM  ADVISORY BOARD CO Financials
Mar-21-17 10:54AM  Jazz Sleep Disorder Drug Positive in Phase III Studies
Mar-20-17 10:10AM  BioDelivery (BDSI) Q4 Loss Wider Than Expected; Sales Meet Zacks
Mar-17-17 09:58AM  Teva Launches Authorized Generic of Allergan's Minastrin
Mar-16-17 11:20AM  Jazz Initiates Phase III Study for Narcolepsy Candidate Zacks
06:06AM  ADVISORY BOARD CO Files SEC form 10-K, Annual Report
Mar-15-17 03:47PM  AstraZeneca's Cancer Drug Lynparza Positive in Phase III
11:13AM  Community Health Continues Divestiture, to Sell 4 Hospitals Zacks
Mar-14-17 04:52PM  Teladoc Continues to Grow in Booming Telehealth Industry Zacks
01:33PM  Advisory Board fights off potential board takeover at bizjournals.com
08:15AM  Post Earnings Coverage as Priceline's Q4 Bottom-line Surged 32% Y-o-Y; Beat Forecasts Accesswire
Mar-06-17 03:07PM  Advisory Board and Elliott Management Reach a Standstill at Investopedia
Mar-03-17 05:24PM  Elliott Settles With Advisory Board as Strategic Review Continues at TheStreet
Mar-02-17 10:25AM  The Advisory Board Co. :ABCO-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017
Mar-01-17 04:01PM  ADVISORY BOARD CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:22AM  Edited Transcript of ABCO earnings conference call or presentation 28-Feb-17 10:30pm GMT
Feb-28-17 04:10PM  The Advisory Board Company Reports Fourth Quarter And Full-Year 2016 Results PR Newswire
07:07AM  Q4 2016 Advisory Board Co Earnings Release - After Market Close
Feb-23-17 09:45AM  [2/23] Today's Top 10 Long/Short Estimize Signal Scores
Feb-17-17 02:54PM  JPMorgan Doesn't Advise Buying Advisory Board, Despite 'Strategic Alternative' Talk
08:05AM  Analysts' Actions -- Arista, Capital One, Avis, Workday and More
Feb-09-17 04:36PM  These top 20 D.C.-area employers have most at stake in H-1B visa overhaul at bizjournals.com
Feb-08-17 12:43PM  [2/8] This Weeks Earnings Revisions Movers - Tech and Consumer Discretionary Lead
Feb-06-17 03:59PM  Activist-Pressured Advisory Board Launches Strategic Review
02:03PM  Advisory Board confirms it is evaluating a potential sale at bizjournals.com
08:35AM  ADVISORY BOARD CO Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:00AM  The Advisory Board Company Announces Exploration of Strategic Alternatives PR Newswire
Feb-03-17 09:13AM  The Market In 5 Minutes: Amazon Lower, Payrolls Higher
08:20AM  Report: Advisory Board interviewing banks for potential sale at bizjournals.com
Feb-02-17 02:47PM  Advisory Board Said to Interview Banks About Possible Sale
Feb-01-17 11:30AM  The Advisory Board Company to Report Fourth Quarter and Year-end Financial Results After Market Close on February 28, 2017 PR Newswire
09:56AM  McAuliffe confirms anchor lease with Nestlé in Rosslyn at bizjournals.com
Jan-28-17 12:01AM  [$$] Barron's Roundtable, Part 3: Digging Into the Details at Barrons.com
Jan-17-17 04:17PM  Paul Singer's Elliott Management Takes 8.3% Stake in Advisory Board at Investopedia
03:18PM  Advisory Board just laid off more than 200 people. What does this mean for its $60M in tax breaks? at bizjournals.com
01:27PM  Elliott 'Strategic Initiative' Effort at NRG Could Lead to Asset Sales, Buyout
Jan-13-17 10:39AM  Advisory Board Company (ABCO) Enters Overbought Territory
08:35AM  The Advisory Board (ABCO) in Focus: Stock Surges 16.2%
08:30AM  Activist investor buys stake in The Advisory Board Co. at bizjournals.com
Jan-12-17 01:31PM  Activist Paul Singer's Pressure Boosts Advisory Board Stock +16.18%
12:07PM  Why The Advisory Board Company Stock Jumped Today at Motley Fool
Jan-10-17 10:24AM  The Advisory Board Co. Value Analysis (NASDAQ:ABCO) : January 10, 2017
Jan-09-17 07:17AM  The Advisory Board Co. breached its 50 day moving average in a Bullish Manner : ABCO-US : January 9, 2017
Jan-06-17 10:02PM  Urban Institute to get 10 years of tax rebates after move to L'Enfant Plaza at bizjournals.com +6.44%
Jan-04-17 06:03AM  ADVISORY BOARD CO Files SEC form 8-K, Results of Operations and Financial Condition, Costs Associated with Exit or Di
Jan-03-17 04:50PM  The Advisory Board Company Aligns Health Care Capabilities to Enhance Efficiency and Drive Future Growth PR Newswire
Dec-21-16 05:00AM  Employers, Educators, Policymakers Collaborate to Outline Pathway to Middle Class through Health Care Careers PR Newswire
Dec-13-16 05:29PM  How D.C.'s West End stands to be impacted by Obama's post-presidency office plans at bizjournals.com
11:06AM  ETFs with exposure to The Advisory Board Co. : December 13, 2016
Dec-12-16 12:49PM  Hedge Funds Are Dumping The Advisory Board Company (ABCO) at Insider Monkey
09:20AM  Partnerships among Hospitals, Public Agencies, and Community-Based Organizations Can Improve Public Health PR Newswire
Nov-22-16 11:00AM  The Advisory Board Company to Participate in the Piper Jaffray Healthcare Conference on November 30, 2016 PR Newswire
Nov-18-16 12:54PM  ETFs with exposure to The Advisory Board Co. : November 18, 2016
Nov-17-16 12:41PM  Advisory Board Helps Hospitals, Health Systems Achieve more than $1.5 Billion ROI PR Newswire
10:37AM  The Advisory Board Co. :ABCO-US: Earnings Analysis: Q3, 2016 By the Numbers : November 17, 2016
10:00AM  The Advisory Board Company (Nasdaq: ABCO) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire
Nov-09-16 04:29PM  ADVISORY BOARD CO Files SEC form 10-Q, Quarterly Report
Nov-02-16 09:41AM  Four Universities Honored with National Awards for Advances in Student Success PR Newswire -8.19%
12:03AM  Edited Transcript of ABCO earnings conference call or presentation 1-Nov-16 9:30pm GMT
Nov-01-16 05:07PM  Advisory Board misses Street 3Q forecasts
05:04PM  ADVISORY BOARD CO Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
04:10PM  The Advisory Board Company Reports Third Quarter Results PR Newswire
09:40AM  Top College Students Who Lose Small Amounts of Financial Aid More Likely to Drop Out PR Newswire
The Advisory Board Company provides best practices research and insight, technology, consulting and management, and data-enabled services in the United States and internationally. Its best practices research and insight programs include published studies, executive education, proprietary databases and online services, access to experts, executive briefings, and other services. The company's best practices research and insight programs are focused on understanding industry dynamics, identifying best-demonstrated management practices, critically evaluating widely-followed but ineffective practices, and analyzing emerging trends within the health care and education industries. It also offers cloud-based software applications that allow members to combine insights derived from best practices research with their operational and financial data and third-party and proprietary data to benchmark performance; identify and assess revenue, cost, quality, and performance improvement opportunities; and implement identified best practices. In addition, the company provides consulting services that provide on-the-ground support for performance improvement initiatives, as well as best practice professional management of the hospital or medical group areas. Further, it offers data-driven solutions by supporting colleges and universities in targeting qualified prospective students; building relationships with prospective students; and optimizing financial aid resources, as well as strategic, data-driven student engagement, and enrollment management solutions. The provides its services through discrete programs to hospitals, health systems, independent medical groups, pharmaceutical and biotechnology companies, health care insurers, medical device companies, colleges, universities, and other health care-focused organizations and educational institutions. The Advisory Board Company was founded in 1979 and is headquartered in Washington, District of Columbia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ZUMWALT LEANNE MDirectorJun 07Option Exercise0.004,42304,423Jun 09 04:30 PM
SHAPIRO LEONDirectorJun 07Option Exercise0.004,423019,216Jun 09 04:03 PM
Neaman Mark RDirectorJun 07Option Exercise0.004,423025,316Jun 09 03:56 PM
KINDICK KELTDirectorJun 07Option Exercise0.005,603031,808Jun 09 03:51 PM
Killefer NancyDirectorJun 07Option Exercise0.004,423011,090Jun 09 03:40 PM
GRUA PETER JDirectorJun 07Option Exercise0.004,42304,423Jun 09 02:49 PM
BANSAL SANJU KDirectorJun 07Option Exercise0.004,423070,487Jun 09 02:40 PM
Miller Cormac FChief Product OfficerApr 19Option Exercise16.5875012,43521,503Apr 20 05:00 PM
Miller Cormac FChief Product OfficerApr 19Sale47.3775035,52820,753Apr 20 05:00 PM
SCHWARTZ RICHARD AChief Operating OfficerApr 18Option Exercise0.001,833018,958Apr 20 04:47 PM
Kirshbaum Michael TChief Financial OfficerApr 18Option Exercise0.001,974047,168Apr 20 04:36 PM
Farber Evan RChief Legal OfficerApr 18Option Exercise0.001,22202,610Apr 20 04:33 PM
FELSENTHAL DAVID LPresidentApr 18Option Exercise0.005,397064,547Apr 20 04:30 PM
VAN HOOSE MARYChief Talent OfficerApr 18Option Exercise0.001,833039,084Apr 20 04:50 PM
Musslewhite Robert WChief Executive OfficerApr 18Option Exercise0.008,5540274,843Apr 20 04:55 PM
Miller Cormac FChief Product OfficerApr 18Option Exercise0.001,833021,360Apr 20 05:00 PM
Miller Cormac FChief Product OfficerApr 18Option Exercise0.0031104,703Apr 20 05:00 PM
Miller Cormac FChief Product OfficerApr 12Option Exercise16.5875012,43520,277Apr 13 05:08 PM
Miller Cormac FChief Product OfficerApr 12Sale47.2075035,40019,527Apr 13 05:08 PM
Musslewhite Robert WChief Executive OfficerApr 11Option Exercise0.006,8480268,714Apr 12 09:33 PM
FELSENTHAL DAVID LPresidentApr 11Option Exercise0.004,377060,560Apr 12 09:58 PM
SCHWARTZ RICHARD AChief Operating OfficerApr 11Option Exercise0.001,478017,613Apr 12 09:55 PM
VAN HOOSE MARYChief Talent OfficerApr 11Option Exercise0.001,459037,734Apr 12 09:59 PM
Kirshbaum Michael TChief Financial OfficerApr 11Option Exercise0.001,641045,790Apr 12 09:49 PM
Farber Evan RChief Legal OfficerApr 11Option Exercise0.001,08901,749Apr 12 09:55 PM
Miller Cormac FChief Product OfficerApr 11Option Exercise0.001,491020,008Apr 13 05:08 PM
Miller Cormac FChief Product OfficerApr 10Option Exercise0.0037904,575Apr 13 05:08 PM
Miller Cormac FChief Product OfficerApr 10Option Exercise0.001,541019,028Apr 13 05:08 PM
Musslewhite Robert WChief Executive OfficerApr 10Option Exercise32.7855,9841,835,122297,719Apr 12 09:33 PM
Farber Evan RChief Legal OfficerApr 10Option Exercise0.009830983Apr 12 09:55 PM
Kirshbaum Michael TChief Financial OfficerApr 10Option Exercise36.6610,297377,46452,337Apr 12 09:49 PM
VAN HOOSE MARYChief Talent OfficerApr 10Option Exercise0.001,329036,715Apr 12 09:59 PM
SCHWARTZ RICHARD AChief Operating OfficerApr 10Option Exercise37.1010,023371,85424,187Apr 12 09:55 PM
FELSENTHAL DAVID LPresidentApr 10Option Exercise0.004,128057,384Apr 12 09:58 PM
Musslewhite Robert WChief Executive OfficerApr 10Sale47.4811,000522,251261,866Apr 12 09:33 PM
Miller Cormac FChief Product OfficerApr 05Option Exercise16.5875012,43518,237Apr 07 07:07 PM
Miller Cormac FChief Product OfficerApr 05Sale46.7075035,02517,487Apr 07 07:07 PM
FELSENTHAL DAVID LPresidentApr 03Option Exercise43.8312,020526,83765,276Apr 04 09:58 PM
FELSENTHAL DAVID LPresidentApr 03Sale46.8412,020562,98453,256Apr 04 09:58 PM
Miller Cormac FChief Product OfficerApr 02Option Exercise0.0079804,462Apr 04 09:48 PM
Farber Evan RChief Legal OfficerMar 24Option Exercise43.835,656247,9025,656Mar 28 02:59 PM
FELSENTHAL DAVID LPresidentMar 24Option Exercise43.8312,020526,83765,276Mar 28 03:44 PM
FELSENTHAL DAVID LPresidentMar 24Sale47.0012,020564,94053,256Mar 28 03:44 PM
Farber Evan RChief Legal OfficerMar 24Sale48.005,656271,4880Mar 28 02:59 PM
FELSENTHAL DAVID LPresidentMar 16Option Exercise16.5832,000530,56085,256Mar 20 05:44 PM
Miller Cormac FChief Product OfficerMar 16Option Exercise16.588,160135,29325,647Mar 20 06:08 PM
FELSENTHAL DAVID LPresidentMar 16Sale45.0132,0001,440,32053,256Mar 20 05:44 PM
Miller Cormac FChief Product OfficerMar 16Sale44.838,160365,81317,487Mar 20 06:08 PM
Miller Cormac FChief Product OfficerMar 01Option Exercise16.5875012,43518,237Mar 03 09:04 AM
Miller Cormac FChief Product OfficerMar 01Sale45.1675033,87017,487Mar 03 09:04 AM
Miller Cormac FChief Product OfficerFeb 15Option Exercise16.5875012,43518,237Feb 17 01:46 PM
Miller Cormac FChief Product OfficerFeb 15Sale47.5075035,62517,487Feb 17 01:46 PM
Musslewhite Robert WChief Executive OfficerFeb 13Option Exercise16.585,50091,190260,811Feb 15 05:06 PM
Musslewhite Robert WChief Executive OfficerFeb 13Sale47.245,500259,820255,311Feb 15 05:06 PM
VAN HOOSE MARYChief Talent OfficerFeb 07Option Exercise43.838,484371,85443,870Feb 08 08:50 PM
VAN HOOSE MARYChief Talent OfficerFeb 07Sale46.848,484397,39135,386Feb 08 08:50 PM
Miller Cormac FChief Product OfficerFeb 01Option Exercise16.5875012,43518,237Feb 03 11:54 AM
Miller Cormac FChief Product OfficerFeb 01Sale45.8975034,41817,487Feb 03 11:54 AM
VAN HOOSE MARYChief Talent OfficerJan 19Option Exercise16.582,00033,16037,386Jan 20 04:57 PM
VAN HOOSE MARYChief Talent OfficerJan 19Sale41.442,00082,88035,386Jan 20 04:57 PM
Miller Cormac FChief Product OfficerJan 18Option Exercise16.5875012,43518,237Jan 20 11:46 AM
Miller Cormac FChief Product OfficerJan 18Sale40.5375030,39817,487Jan 20 11:46 AM
Musslewhite Robert WChief Executive OfficerJan 09Option Exercise16.585,50091,190260,811Jan 11 05:02 PM
Musslewhite Robert WChief Executive OfficerJan 09Sale35.765,500196,680255,311Jan 11 05:02 PM
Miller Cormac FChief Product OfficerJan 04Option Exercise16.5875012,43518,237Jan 09 06:01 AM
Miller Cormac FChief Product OfficerJan 04Sale32.6875024,50717,487Jan 09 06:01 AM
VAN HOOSE MARYChief Talent OfficerJan 03Option Exercise16.582,00033,16037,386Jan 04 10:39 AM
VAN HOOSE MARYChief Talent OfficerJan 03Sale33.492,00066,98035,386Jan 04 10:39 AM
Miller Cormac FChief Product OfficerDec 20Option Exercise16.5875012,43518,237Dec 22 07:35 PM
Kirshbaum Michael TChief Financial OfficerDec 20Option Exercise16.582,40039,79245,503Dec 22 07:51 PM
Kirshbaum Michael TChief Financial OfficerDec 20Sale32.922,40079,00843,103Dec 22 07:51 PM
Miller Cormac FChief Product OfficerDec 20Sale32.8575024,63817,487Dec 22 07:35 PM
VAN HOOSE MARYChief Talent OfficerDec 19Option Exercise16.582,00033,16037,386Dec 21 06:15 PM
VAN HOOSE MARYChief Talent OfficerDec 19Sale32.482,00064,96035,386Dec 21 06:15 PM
Musslewhite Robert WChief Executive OfficerDec 12Option Exercise16.585,50091,190259,084Dec 14 07:24 PM
Musslewhite Robert WChief Executive OfficerDec 12Sale33.875,500186,298255,311Dec 14 07:24 PM
Miller Cormac FChief Product OfficerDec 07Option Exercise16.5875012,43518,237Dec 09 08:39 AM
Miller Cormac FChief Product OfficerDec 07Sale32.5875024,43517,487Dec 09 08:39 AM
VAN HOOSE MARYChief Talent OfficerDec 06Option Exercise16.582,00033,16037,386Dec 08 08:04 PM
VAN HOOSE MARYChief Talent OfficerDec 06Sale31.982,00063,96035,386Dec 08 08:04 PM
Miller Cormac FChief Product OfficerNov 23Option Exercise16.5875012,43518,237Nov 29 10:25 AM
Miller Cormac FChief Product OfficerNov 23Sale36.7075027,52517,487Nov 29 10:25 AM
VAN HOOSE MARYChief Talent OfficerNov 22Option Exercise16.582,00033,16037,386Nov 23 12:44 PM
VAN HOOSE MARYChief Talent OfficerNov 22Sale36.982,00073,96035,386Nov 23 12:44 PM
Kirshbaum Michael TChief Financial OfficerNov 21Option Exercise16.582,40039,79245,503Nov 23 12:27 PM
Kirshbaum Michael TChief Financial OfficerNov 21Sale36.052,40086,52043,103Nov 23 12:27 PM
Musslewhite Robert WChief Executive OfficerNov 14Option Exercise16.585,50091,190260,811Nov 16 12:57 PM
Musslewhite Robert WChief Executive OfficerNov 14Sale32.885,500180,840255,311Nov 16 12:57 PM
VAN HOOSE MARYChief Talent OfficerNov 10Option Exercise16.582,00033,16037,386Nov 10 09:13 PM
VAN HOOSE MARYChief Talent OfficerNov 10Sale34.262,00068,52035,386Nov 10 09:13 PM
Miller Cormac FChief Product OfficerNov 09Option Exercise16.5875012,43518,237Nov 10 05:09 PM
Miller Cormac FChief Product OfficerNov 09Sale34.6375025,97317,487Nov 10 05:09 PM
Miller Cormac FChief Product OfficerOct 26Option Exercise16.5875012,43518,237Oct 28 01:15 PM
Miller Cormac FChief Product OfficerOct 26Sale41.6375031,22317,487Oct 28 01:15 PM
Kirshbaum Michael TChief Financial OfficerOct 20Option Exercise16.582,40039,79245,503Oct 24 09:20 PM
Kirshbaum Michael TChief Financial OfficerOct 20Sale42.802,400102,72043,103Oct 24 09:20 PM
Miller Cormac FChief Product OfficerOct 12Option Exercise16.5875012,43518,237Oct 14 03:49 PM
Miller Cormac FChief Product OfficerOct 12Sale43.1575032,36317,487Oct 14 03:49 PM
Musslewhite Robert WChief Executive OfficerOct 10Option Exercise16.585,50091,190260,811Oct 12 05:04 PM
Musslewhite Robert WChief Executive OfficerOct 10Sale43.895,500241,395255,311Oct 12 05:04 PM